Wockhardt Ltd
NSE:WOCKPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
Wockhardt Ltd
NSE:WOCKPHARMA
|
IN |
|
Amdocs Ltd
NASDAQ:DOX
|
US |
|
Noevir Holdings Co Ltd
TSE:4928
|
JP |
|
C
|
Cross River Ventures Corp
CNSX:CRVC
|
CA |
|
I
|
ICSGlobal Ltd
ASX:ICS
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is WOCKPHARMA's stock price target?
Not Available
WOCKPHARMA doesn't have any price targets made by Wall Street professionals.
What is Wockhardt Ltd's Revenue forecast?
Projected CAGR
5%
For the last 13 years the compound annual growth rate for Wockhardt Ltd's revenue is -3%. The projected CAGR for the next 8 years is 5%.
What is Wockhardt Ltd's Operating Income forecast?
Projected CAGR
8%
For the last 13 years the compound annual growth rate for Wockhardt Ltd's operating income is -14%. The projected CAGR for the next 8 years is 8%.